Progress in the treatment of respiratory virus infection in children
10.3760/cma.j.issn.1673-4408.2021.01.011
- VernacularTitle:儿童呼吸道病毒感染治疗进展
- Author:
Changjiang YU
;
Yongsheng XU
- From:
International Journal of Pediatrics
2021;48(1):43-46
- CountryChina
- Language:Chinese
-
Abstract:
Respiratory virus remains to be an important pathogen of respiratory disease in children.The disease can occur in all age groups, especially in young children.Most viral infections have a good prognosis, but special viruses still cause great harm to the health of children.Respiratory viral therapy includes symptomatic therapy, broad-spectrum antiviral drugs, drugs that directly target the viral replication cycle, drugs that attenuate the inflammatory response, and anti-viral nanodrugs.New antiviral drugs are urgently needed to develop.The repurposing of the existing therapeutic agents previously designed for other virus infections is also an effective way.The treatment of respiratory virus infection has become an important topic in clinical research.
